Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study in Pediatric Patients with Rett Syndrome September 4, 2019 - NASDAQ Companies 0 » View More News for September 04, 2019
